5026 - 5050 of 8399 Results
Title
Year
-
RESTRICTEDTitle: Social Impact of Connected Landmark Lighting: A Social Sensing ApproachJournal Name: IEEE Internet of Things MagazinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 3Issue #: 1Start Page: 64End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/iotm.0001.1900088Citation Count: 1
-
OPENTitle: Three-Plane–assembled Deep Learning Segmentation of GliomasJournal Name: Radiology: Artificial IntelligencePublisher: Radiological Society of North America (RSNA)Vol: 2Issue #: 2Start Page: e190011End Page: e190011Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/ryai.2020190011Best OA location URL: https://pubs.rsna.org/doi/pdf/10.1148/ryai.2020190011Citation Count: 23
-
RESTRICTEDTitle: β-adrenoreceptors and the risk of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 247End Page: 254Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30400-4Citation Count: 46
- An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative Diseases2020RESTRICTEDTitle: An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative DiseasesJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 3Start Page: 576End Page: 576Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9030576Best OA location URL: https://www.mdpi.com/2073-4409/9/3/576/pdf?version=1585198756Citation Count: 25
- Outcome measurement in functional neurological disorder: a systematic review and recommendations2020RESTRICTEDTitle: Outcome measurement in functional neurological disorder: a systematic review and recommendationsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 6Start Page: 638End Page: 649Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2019-322180Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/6/638.full.pdfCitation Count: 82
- Personalized prediction of depression in patients with newly diagnosed Parkinson's disease: A prospective cohort study2020RESTRICTEDTitle: Personalized prediction of depression in patients with newly diagnosed Parkinson's disease: A prospective cohort studyJournal Name: Journal of Affective DisordersPublisher: Elsevier BVVol: 268Issue #:Start Page: 118End Page: 126Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jad.2020.02.046Citation Count: 23
- Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue Homogenates2020OPENTitle: Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue HomogenatesJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 15Issue #: 4Start Page: 824End Page: 829Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.9b01044Best OA location URL: https://eprints.whiterose.ac.uk/159502/1/acschembio.9b01044.pdfCitation Count: 10
- Frequency of and risk factors for potentially inappropriate medication use in Parkinson’s disease2020OPENTitle: Frequency of and risk factors for potentially inappropriate medication use in Parkinson’s diseaseJournal Name: Age and AgeingPublisher: Oxford University Press (OUP)Vol: 49Issue #: 5Start Page: 786End Page: 792Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/ageing/afaa033Best OA location URL: https://academic.oup.com/ageing/article-pdf/49/5/786/33677028/afaa033.pdfCitation Count: 16
- Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide2020OPENTitle: Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and SafinamideJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 343End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12921Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12921Citation Count: 255
- Contingent negative variation: a biomarker of abnormal attention in functional movement disorders2020OPENTitle: Contingent negative variation: a biomarker of abnormal attention in functional movement disordersJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: 6Start Page: 985End Page: 994Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/ene.14189Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14189Citation Count: 17
- Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease2020OPENTitle: Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 5Start Page: 632End Page: 632Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2019.5154Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2761854/jamaneurology_ossenkoppele_2020_oi_190119.pdfCitation Count: 106
- Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s disease2020OPENTitle: Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s diseaseJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-020-0401-2Best OA location URL: https://www.nature.com/articles/s41597-020-0401-2.pdfCitation Count: 92
-
RESTRICTEDTitle: Handheld Cough Testing: A Novel Tool for Cough Assessment and Dysphagia ScreeningJournal Name: DysphagiaPublisher: Springer Science and Business Media LLCVol: 35Issue #: 6Start Page: 993End Page: 1000Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00455-020-10097-zCitation Count: 21
- Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease2020OPENTitle: Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 947End Page: 958Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28009Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28009Citation Count: 80
-
OPENTitle: Diphasic Worsening of Freezing of Gait in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 325End Page: 328Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12918Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12918Citation Count: 11
- Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate2020OPENTitle: Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidateJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 138Issue #:Start Page: 104789End Page: 104789Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104789Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104789Citation Count: 30
-
OPENTitle: Validation of a Parkinson Disease Predictive Model in a Population-Based StudyJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/2857608Best OA location URL: https://doi.org/10.1155/2020/2857608Citation Count: 9
-
OPENTitle: Well Water and Parkinson’s Disease in Medicare Beneficiaries: A Nationwide Case-Control StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 693End Page: 705Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-191793Best OA location URL: https://europepmc.org/articles/pmc7342021?pdf=renderCitation Count: 11
- A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigra2020OPENTitle: A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigraJournal Name: Aging CellPublisher: WileyVol: 19Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13115Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13115Citation Count: 60
- Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis2020RESTRICTEDTitle: Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysisJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 4Start Page: 426End Page: 433Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2019-322169Best OA location URL: https://scholarlypublications.universiteitleiden.nl/access/item%3A3627324/viewCitation Count: 50
- Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study2020OPENTitle: Disease progression and prognostic factors in multiple system atrophy: A prospective cohort studyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104813End Page: 104813Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104813Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104813Citation Count: 66
- Longitudinal change in autonomic symptoms predicts activities of daily living and depression in Parkinson’s disease2020RESTRICTEDTitle: Longitudinal change in autonomic symptoms predicts activities of daily living and depression in Parkinson’s diseaseJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 3Start Page: 223End Page: 230Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00672-7Best OA location URL: https://cdr.lib.unc.edu/downloads/v118rp109Citation Count: 21
- Probing Reversible Guest Binding with Hyperpolarized 129Xe-NMR: Characteristics and Applications for Cucurbit[n]urils2020RESTRICTEDTitle: Probing Reversible Guest Binding with Hyperpolarized 129Xe-NMR: Characteristics and Applications for Cucurbit[n]urilsJournal Name: MoleculesPublisher: MDPI AGVol: 25Issue #: 4Start Page: 957End Page: 957Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/molecules25040957Best OA location URL: https://www.mdpi.com/1420-3049/25/4/957/pdf?version=1582525706Citation Count: 9
-
OPENTitle: Tossing and Turning in Bed: Nocturnal Movements in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 959End Page: 968Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28006Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/220357/220357.pdfCitation Count: 48
- Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathology2020OPENTitle: Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104810End Page: 104810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104810Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104810Citation Count: 34